Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Women's Health and Genetics/Laboratory Corporation of America, |
RCV001280664 | SCV001467954 | likely benign | not specified | 2024-03-30 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001664796 | SCV001872944 | uncertain significance | not provided | 2023-12-11 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant does not alter protein structure/function; Co-observed with a 22q11.2 deletion that included the LZTR1 gene in an individual with features of both 22q11.2 deletion syndrome and Noonan syndrome (PMID: 35689529); This variant is associated with the following publications: (PMID: 32310333, 35689529) |
Labcorp Genetics |
RCV001664796 | SCV002323987 | likely benign | not provided | 2025-01-30 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002393683 | SCV002703870 | likely benign | Hereditary cancer-predisposing syndrome; Cardiovascular phenotype | 2020-08-17 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV001664796 | SCV005041977 | likely benign | not provided | 2024-04-01 | criteria provided, single submitter | clinical testing | LZTR1: BS1 |
Prevention |
RCV004734089 | SCV005353708 | likely benign | LZTR1-related disorder | 2024-03-04 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |